Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Disruptive Pharma AB
AB
Active
Org 5591746085
Uppsala
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2018 · 7 years old
5-9 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Disruptive Pharma AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
1M
1M
1M
0M
0M
2020: 0M
0M
2020
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 1M
1M
2023
2024: 1M (0% vs 2023)
1M
0%
2024
EBITDA
SEK millions
0M
-9M
-18M
-27M
-36M
2020: 0M
0M
2020
2021: -10M
-10M
2021
2022: -20M (-100% vs 2021)
-20M
-100%
2022
2023: -25M (-25% vs 2022)
-25M
-25%
2023
2024: -29M (-16% vs 2023)
-29M
-16%
2024
Income statement
SEK thousands
Item
2024
2023
2022
2021
2020
Revenue
1 160
910
459
138
0
Staff expenses
—
—
—
—
—
EBITDA
−29 158
−24 865
−19 732
−10 220
0
Depreciation & amort.
−292
−289
−92
−0
−0
EBIT
−29 450
−25 154
−19 824
−10 220
0
Net financials
450
763
207
3
—
Profit before tax
−29 000
−24 391
−19 617
−10 217
0
Tax
−0
−0
−0
−0
−0
Net profit
−29 000
−24 391
−19 617
−10 217
0
Balance sheet
SEK thousands
Item
2024
2023
2022
2021
2020
Total assets
14 203
26 186
46 260
17 150
50
Equity
325
325
1 716
333
50
Long-term debt
0
0
0
0
0
Short-term debt
13 878
25 861
44 544
16 817
0
Total debt
13 878
25 861
44 544
16 817
—
Financial ratios
5-year trend
EBITDA margin
<−999 %
This company
15,8 %
Market median
This company
Market median
>999% below market
2020
2024
Equity ratio
2,3 %
This company
38,2 %
Market median
This company
Market median
94% below market
2020
2024
Return on equity
<−999 %
This company
18,4 %
Market median
This company
Market median
>999% below market
2020
2024
Net profit margin
<−999 %
This company
8,1 %
Market median
This company
Market median
>999% below market
2020
2024
Asset turnover
0,08×
This company
1,12×
Market median
This company
Market median
93% below market
2020
2024
Debt / equity
42,70×
This company
0,62×
Market median
This company
Market median
>999% above market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Disruptive Pharma AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
